Matches in SemOpenAlex for { <https://semopenalex.org/work/W1738339035> ?p ?o ?g. }
- W1738339035 endingPage "52" @default.
- W1738339035 startingPage "1947" @default.
- W1738339035 abstract "High-dose interferon alfa-2b (IFN-alpha2b) as adjuvant therapy for melanoma is associated with substantial dose-limiting toxicity. It has been suggested that the 1-month intravenous (i.v.) induction regimen may be sufficient to reduce the risk of relapse and death.The Hellenic Cooperative Oncology Group is conducting a multicenter, randomized trial of 1-month i.v. induction versus 1 year of adjuvant IFN-alpha2b therapy in patients with stage IIB/III melanoma. Adverse events reported by the first 200 patients to complete therapy are described.Both induction and maintenance regimens were well tolerated. The most common toxicities were flu-like and gastrointestinal symptoms, neutropenia, liver toxicity, and neurologic toxicity. The incidence of grade 3/4 toxicity was low and occurred mainly during the induction phase in both arms. Dose was reduced in 31% of patients during induction. Only 2% of patients discontinued. Dose was reduced in 8% of patients during maintenance and only 5% of patients discontinued.Intravenous induction with 15 MIU/m2/day IFN-alpha2b is well tolerated. Efficacy results from this trial are eagerly anticipated." @default.
- W1738339035 created "2016-06-24" @default.
- W1738339035 creator A5007991935 @default.
- W1738339035 creator A5011281937 @default.
- W1738339035 creator A5012112204 @default.
- W1738339035 creator A5018787724 @default.
- W1738339035 creator A5031587640 @default.
- W1738339035 creator A5039349296 @default.
- W1738339035 creator A5041575636 @default.
- W1738339035 creator A5047282415 @default.
- W1738339035 creator A5047514408 @default.
- W1738339035 creator A5054375277 @default.
- W1738339035 creator A5075321487 @default.
- W1738339035 creator A5084726489 @default.
- W1738339035 creator A5090633646 @default.
- W1738339035 date "2004-07-28" @default.
- W1738339035 modified "2023-09-27" @default.
- W1738339035 title "Tolerability of adjuvant high-dose interferon alfa-2b: 1 month versus 1 year--a Hellenic Cooperative Oncology Group study." @default.
- W1738339035 cites W1552882882 @default.
- W1738339035 cites W1828940258 @default.
- W1738339035 cites W1908752382 @default.
- W1738339035 cites W1937560614 @default.
- W1738339035 cites W2048048309 @default.
- W1738339035 cites W2118449798 @default.
- W1738339035 cites W2131772284 @default.
- W1738339035 cites W96088601 @default.
- W1738339035 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15274382" @default.
- W1738339035 hasPublicationYear "2004" @default.
- W1738339035 type Work @default.
- W1738339035 sameAs 1738339035 @default.
- W1738339035 citedByCount "9" @default.
- W1738339035 countsByYear W17383390352012 @default.
- W1738339035 countsByYear W17383390352014 @default.
- W1738339035 countsByYear W17383390352016 @default.
- W1738339035 countsByYear W17383390352017 @default.
- W1738339035 countsByYear W17383390352019 @default.
- W1738339035 crossrefType "journal-article" @default.
- W1738339035 hasAuthorship W1738339035A5007991935 @default.
- W1738339035 hasAuthorship W1738339035A5011281937 @default.
- W1738339035 hasAuthorship W1738339035A5012112204 @default.
- W1738339035 hasAuthorship W1738339035A5018787724 @default.
- W1738339035 hasAuthorship W1738339035A5031587640 @default.
- W1738339035 hasAuthorship W1738339035A5039349296 @default.
- W1738339035 hasAuthorship W1738339035A5041575636 @default.
- W1738339035 hasAuthorship W1738339035A5047282415 @default.
- W1738339035 hasAuthorship W1738339035A5047514408 @default.
- W1738339035 hasAuthorship W1738339035A5054375277 @default.
- W1738339035 hasAuthorship W1738339035A5075321487 @default.
- W1738339035 hasAuthorship W1738339035A5084726489 @default.
- W1738339035 hasAuthorship W1738339035A5090633646 @default.
- W1738339035 hasConcept C121608353 @default.
- W1738339035 hasConcept C126322002 @default.
- W1738339035 hasConcept C141071460 @default.
- W1738339035 hasConcept C143998085 @default.
- W1738339035 hasConcept C197934379 @default.
- W1738339035 hasConcept C2776694085 @default.
- W1738339035 hasConcept C2777063308 @default.
- W1738339035 hasConcept C2777701055 @default.
- W1738339035 hasConcept C2777863537 @default.
- W1738339035 hasConcept C2777982462 @default.
- W1738339035 hasConcept C2778375690 @default.
- W1738339035 hasConcept C2778715236 @default.
- W1738339035 hasConcept C2781228144 @default.
- W1738339035 hasConcept C2781413609 @default.
- W1738339035 hasConcept C29730261 @default.
- W1738339035 hasConcept C71924100 @default.
- W1738339035 hasConcept C90924648 @default.
- W1738339035 hasConceptScore W1738339035C121608353 @default.
- W1738339035 hasConceptScore W1738339035C126322002 @default.
- W1738339035 hasConceptScore W1738339035C141071460 @default.
- W1738339035 hasConceptScore W1738339035C143998085 @default.
- W1738339035 hasConceptScore W1738339035C197934379 @default.
- W1738339035 hasConceptScore W1738339035C2776694085 @default.
- W1738339035 hasConceptScore W1738339035C2777063308 @default.
- W1738339035 hasConceptScore W1738339035C2777701055 @default.
- W1738339035 hasConceptScore W1738339035C2777863537 @default.
- W1738339035 hasConceptScore W1738339035C2777982462 @default.
- W1738339035 hasConceptScore W1738339035C2778375690 @default.
- W1738339035 hasConceptScore W1738339035C2778715236 @default.
- W1738339035 hasConceptScore W1738339035C2781228144 @default.
- W1738339035 hasConceptScore W1738339035C2781413609 @default.
- W1738339035 hasConceptScore W1738339035C29730261 @default.
- W1738339035 hasConceptScore W1738339035C71924100 @default.
- W1738339035 hasConceptScore W1738339035C90924648 @default.
- W1738339035 hasIssue "3b" @default.
- W1738339035 hasLocation W17383390351 @default.
- W1738339035 hasOpenAccess W1738339035 @default.
- W1738339035 hasPrimaryLocation W17383390351 @default.
- W1738339035 hasRelatedWork W2009822178 @default.
- W1738339035 hasRelatedWork W2027851148 @default.
- W1738339035 hasRelatedWork W2044389879 @default.
- W1738339035 hasRelatedWork W2087848499 @default.
- W1738339035 hasRelatedWork W2142625039 @default.
- W1738339035 hasRelatedWork W2325203342 @default.
- W1738339035 hasRelatedWork W2333697764 @default.
- W1738339035 hasRelatedWork W3164492765 @default.
- W1738339035 hasRelatedWork W4280495737 @default.
- W1738339035 hasRelatedWork W4280538357 @default.